International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Capsaicin 0.025% and Doxepin 3.3% Cream

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue

Page(s): 506

Capsaicin 0.025% and Doxepin 3.3% Cream Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Capsaicin 0.025% and Doxepin 3.3% Cream. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, capsaicin, doxepin, analgesic, analgesia, topical preparations, pain relief, postherpetic neuralgia, diabetic neuropathy, osteoarthritis, rheumatoid arthritis, muscle pain, rheumatic pain, medicinal plant

Related Categories: FORMULATIONS, PAIN MANAGEMENT, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Capsaicin 0.025% and Doxepin 3.3% Cream Allen Loyd V Jr	Nov/Dec 2016 Pg. 506
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient McElhiney Linda F	May/Jun 2011 Pg. 194-199
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Capsaicin 0.05% Clear Medication Stick Allen Loyd V Jr	Nov/Dec 2010 Pg. 517
Doxepin Hydrochloride 5% in Cetaphil Cream Allen Loyd V Jr	Jul/Aug 2020 Pg. 314
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott	Mar/Apr 2015 Pg. 167-173
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vail Jane	Jan/Feb 2003 Pg. 21-23
NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Nov/Dec 2020 Pg. 446-448
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane	Nov/Dec 2008 Pg. 498-504
Postherpetic Neuralgia Angelle Patsy	Jan/Feb 2000 Pg. 27-29
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient McElhiney Linda F	Sep/Oct 2011 Pg. 386-387
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott	Mar/Apr 2015 Pg. 161-166
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Allen Loyd V Jr	May/Jun 2017 Pg. 234
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Zugerman Jessie Jean M, Reed Thomas C	Nov/Dec 2007 Pg. 514-519
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 513
Return to Top